- Home
- SDSTW vs BDRX Comparison
SDSTW vs BDRX Comparison
Compare SDSTW & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SDSTW
- BDRX
- Stock Information
- Founded
- SDSTW N/A
- BDRX 2000
- Country
- SDSTW United States
- BDRX United Kingdom
- Employees
- SDSTW 8
- BDRX N/A
- Industry
- SDSTW
- BDRX Biotechnology: Pharmaceutical Preparations
- Sector
- SDSTW
- BDRX Health Care
- Exchange
- SDSTW Nasdaq
- BDRX Nasdaq
- Market Cap
- SDSTW 3.4M
- BDRX 3.9M
- IPO Year
- SDSTW N/A
- BDRX N/A
- Fundamental
- Price
- SDSTW $0.10
- BDRX $6.75
- Analyst Decision
- SDSTW
- BDRX
- Analyst Count
- SDSTW 0
- BDRX 0
- Target Price
- SDSTW N/A
- BDRX N/A
- AVG Volume (30 Days)
- SDSTW 41.6K
- BDRX 48.5K
- Earning Date
- SDSTW 03-26-2025
- BDRX 09-23-2025
- Dividend Yield
- SDSTW N/A
- BDRX N/A
- EPS Growth
- SDSTW N/A
- BDRX N/A
- EPS
- SDSTW N/A
- BDRX N/A
- Revenue
- SDSTW N/A
- BDRX N/A
- Revenue This Year
- SDSTW N/A
- BDRX N/A
- Revenue Next Year
- SDSTW N/A
- BDRX N/A
- P/E Ratio
- SDSTW N/A
- BDRX N/A
- Revenue Growth
- SDSTW N/A
- BDRX N/A
- 52 Week Low
- SDSTW $0.10
- BDRX $5.00
- 52 Week High
- SDSTW $0.12
- BDRX $108.90
- Technical
- Relative Strength Index (RSI)
- SDSTW 55.59
- BDRX 53.33
- Support Level
- SDSTW $0.08
- BDRX $6.31
- Resistance Level
- SDSTW $0.13
- BDRX $7.00
- Average True Range (ATR)
- SDSTW 0.02
- BDRX 0.40
- MACD
- SDSTW 0.00
- BDRX 0.07
- Stochastic Oscillator
- SDSTW 64.49
- BDRX 52.31
About SDSTW Stardust Power Inc. Warrant
Stardust Power Inc is developing a lithium refinery at its Facility in Muskogee, Oklahoma, with planned capacity of producing up to 50,000 metric tons per annum of BGLC once fully operational. The company will source lithium brine feedstock from various suppliers and may make investments upstream to secure additional feedstock. The Company seeks to sell its products to electric vehicle (EV) manufacturers as the primary market, with potential applications in other areas such as battery manufacturers, the U.S. military, and original equipment manufacturers (OEMs).
About BDRX Biodexa Pharmaceuticals plc
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.